Cargando…

Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana

BACKGROUND: Intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) decreases placental parasitaemia and improves birth outcomes. Currently, WHO recommends three or more doses of SP given during antenatal care (ANC), spaced one month apart after 16 weeks of...

Descripción completa

Detalles Bibliográficos
Autores principales: Anto, Francis, Agongo, Ibrahim Haruna, Asoala, Victor, Awini, Elizabeth, Oduro, Abraham Rexford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582795/
https://www.ncbi.nlm.nih.gov/pubmed/31275401
http://dx.doi.org/10.1155/2019/6712685
_version_ 1783428397734559744
author Anto, Francis
Agongo, Ibrahim Haruna
Asoala, Victor
Awini, Elizabeth
Oduro, Abraham Rexford
author_facet Anto, Francis
Agongo, Ibrahim Haruna
Asoala, Victor
Awini, Elizabeth
Oduro, Abraham Rexford
author_sort Anto, Francis
collection PubMed
description BACKGROUND: Intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) decreases placental parasitaemia and improves birth outcomes. Currently, WHO recommends three or more doses of SP given during antenatal care (ANC), spaced one month apart after 16 weeks of gestation till delivery. This study determined the level of uptake of SP and its association with birth outcomes in rural northern Ghana. METHODS: A survey was carried out at the War Memorial Hospital in Navrongo, Ghana, among mothers who had delivered within ten weeks and were seeking postnatal care. Data on time of first ANC, number of visits, receipt of IPTp-SP, and birth outcomes were extracted from the antenatal records of 254 mothers. Mothers were interviewed on their background characteristics and obstetric history. Chi-square tests and logistic regression were carried out to determine association between antenatal indicators, uptake of IPTp-SP, and birth outcomes using Stata version 13. RESULTS: Uptake of three-five doses of SP was IPT3 =76.4%, IPT4 =37.3%, and IPT5 = 16.0%. Receipt of first dose of SP at 16, 17-24, and 25-36 weeks of gestation was 16.9%, 56.7%, and 26.4%, respectively. Taking the first dose of SP during the second trimester allowed for taking ≥3 doses of SP compared to taking the first dose during the third trimester (χ2 = 60.1, p<0.001). Women who made ≥4 visits were more likely to receive ≥3 doses of SP compared to those who made <4 visits (χ2 = 87.6, p<0.001). Women who received ≥ 3 doses of SP were more likely (OR = 3.3; 95% CI: 1.69-6.33) to give birth at term and also have normal weight babies (OR =4.0; 95% CI: 1.98-8.06). CONCLUSION: Uptake of three or more doses of SP contributed to improved pregnancy outcomes. Increased efforts towards improving early ANC attendance could increase uptake of SP and improve pregnancy outcomes.
format Online
Article
Text
id pubmed-6582795
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65827952019-07-04 Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana Anto, Francis Agongo, Ibrahim Haruna Asoala, Victor Awini, Elizabeth Oduro, Abraham Rexford J Trop Med Research Article BACKGROUND: Intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) decreases placental parasitaemia and improves birth outcomes. Currently, WHO recommends three or more doses of SP given during antenatal care (ANC), spaced one month apart after 16 weeks of gestation till delivery. This study determined the level of uptake of SP and its association with birth outcomes in rural northern Ghana. METHODS: A survey was carried out at the War Memorial Hospital in Navrongo, Ghana, among mothers who had delivered within ten weeks and were seeking postnatal care. Data on time of first ANC, number of visits, receipt of IPTp-SP, and birth outcomes were extracted from the antenatal records of 254 mothers. Mothers were interviewed on their background characteristics and obstetric history. Chi-square tests and logistic regression were carried out to determine association between antenatal indicators, uptake of IPTp-SP, and birth outcomes using Stata version 13. RESULTS: Uptake of three-five doses of SP was IPT3 =76.4%, IPT4 =37.3%, and IPT5 = 16.0%. Receipt of first dose of SP at 16, 17-24, and 25-36 weeks of gestation was 16.9%, 56.7%, and 26.4%, respectively. Taking the first dose of SP during the second trimester allowed for taking ≥3 doses of SP compared to taking the first dose during the third trimester (χ2 = 60.1, p<0.001). Women who made ≥4 visits were more likely to receive ≥3 doses of SP compared to those who made <4 visits (χ2 = 87.6, p<0.001). Women who received ≥ 3 doses of SP were more likely (OR = 3.3; 95% CI: 1.69-6.33) to give birth at term and also have normal weight babies (OR =4.0; 95% CI: 1.98-8.06). CONCLUSION: Uptake of three or more doses of SP contributed to improved pregnancy outcomes. Increased efforts towards improving early ANC attendance could increase uptake of SP and improve pregnancy outcomes. Hindawi 2019-06-02 /pmc/articles/PMC6582795/ /pubmed/31275401 http://dx.doi.org/10.1155/2019/6712685 Text en Copyright © 2019 Francis Anto et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Anto, Francis
Agongo, Ibrahim Haruna
Asoala, Victor
Awini, Elizabeth
Oduro, Abraham Rexford
Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
title Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
title_full Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
title_fullStr Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
title_full_unstemmed Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
title_short Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
title_sort intermittent preventive treatment of malaria in pregnancy: assessment of the sulfadoxine-pyrimethamine three-dose policy on birth outcomes in rural northern ghana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582795/
https://www.ncbi.nlm.nih.gov/pubmed/31275401
http://dx.doi.org/10.1155/2019/6712685
work_keys_str_mv AT antofrancis intermittentpreventivetreatmentofmalariainpregnancyassessmentofthesulfadoxinepyrimethaminethreedosepolicyonbirthoutcomesinruralnorthernghana
AT agongoibrahimharuna intermittentpreventivetreatmentofmalariainpregnancyassessmentofthesulfadoxinepyrimethaminethreedosepolicyonbirthoutcomesinruralnorthernghana
AT asoalavictor intermittentpreventivetreatmentofmalariainpregnancyassessmentofthesulfadoxinepyrimethaminethreedosepolicyonbirthoutcomesinruralnorthernghana
AT awinielizabeth intermittentpreventivetreatmentofmalariainpregnancyassessmentofthesulfadoxinepyrimethaminethreedosepolicyonbirthoutcomesinruralnorthernghana
AT oduroabrahamrexford intermittentpreventivetreatmentofmalariainpregnancyassessmentofthesulfadoxinepyrimethaminethreedosepolicyonbirthoutcomesinruralnorthernghana